MEDIFAST INC
Close on Oct 19, 2026
- Market cap
- $133.95M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
About Medifast
Miscellaneous Food Preparations & Kindred Products, SIC 2090
Medifast, Inc. provides coach-guided health, wellness, and lifestyle solutions centered on metabolic health and weight management. The company offers structured nutrition programs, such as its 5 & 1 and Optimal Weight plans, alongside proprietary food and nutritional product lines including OPTA VIA Fuelings, OPTA VIA ACTIVE, and OPTA VIA ASCEND. Its offerings combine scientifically formulated pre-portioned meal replacements, dietary supplements, habit-change blueprints, community support, and a companion mobile application. Medifast serves individual consumers seeking weight reduction, long-term weight maintenance, and metabolic wellness, including individuals who use weight-loss medications.
The company distributes its products and lifestyle plans directly to consumers through an independent network of approximately 16,100 active earning coaches as of late 2025. It targets clients primarily across the United States and operates through domestic and international subsidiaries, including entities registered in Hong Kong and Shanghai. The company's provided filing text does not disclose a specific headquarters location.
Summary of the business section of Medifast's latest annual report, written by StockData.
Company profile
Company
- Legal name
- MEDIFAST INC
- Founded
- 1980
- Headquarters
- Baltimore, MD
- Address
- 1501 S. Clinton Street, Suite 500 21224
- Phone
- (410) 581-8042
- Website
- www.medifast1.com
- Employees
- 380, Dec 31, 2025
- Industry
- Miscellaneous Food Preparations & Kindred Products
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- RSM US LLP, Baltimore, Maryland
Stock & identifiers
- Ticker
- MED
- Exchange
- NYSE
- Shares outstanding
- 11M, Jul 27, 2026
- Public float
- $145.00M, Jun 30, 2025
- Filer category
- Accelerated filer<br>Smaller reporting company
- SEC CIK
- 910329
- CUSIP
- 58470H101
- ISIN
- US58470H1014
- LEI
- 5299000YHQJ21T5KKI80
- EIN
- 13-3714405
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Nicholas Mark Johnson | President | 13,457 |
| Jonathan Barrett MacKenzie | VP, Finance & CAO | 20,838 |
| James P. Maloney | Chief Financial Officer | 37,675 |
| Daniel R. Chard | Director | 336,520 |
| Parsa Kiai | Director | 31,950 |
| Jeffrey Matthew Rose | Director | 11,680 |
| Scott Schlackman | Director | 42,229 |
| Ming Xian | Director | – |
| Andrea B. Thomas | Director | 35,697 |
| Elizabeth A. Geary | Director | 31,225 |
| Michael A. Hoer | Director | 26,139 |
| Jeffrey J. Brown | Director | 33,361 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Daniel Chard | $5.58M | $2.73M | $1.32M | $6 | $116 |
| FY2024 Daniel Chard | $5.61M | $983.51K | $1.16M | $10 | $140 |
| FY2023 Daniel Chard | $7.04M | $2.93M | $1.74M | $39 | $139 |
| FY2022 Daniel Chard | $5.94M | -$710.74K | $1.23M | $63 | $120 |
| FY2021 Daniel Chard | $6.57M | $12.94M | $1.44M | $109 | $129 |
| FY2020 Daniel Chard | $5.54M | $9.91M | $951.88K | $186 | $111 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we employed 380 team members, all employed in the United States, of whom 173 were engaged in manufacturing, logistics and supply chain support, and 207 in marketing, administrative and corporate support functions.”
Corporate history
Events identified from SEC filings